| 000 | 01515 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513143030.0 | ||
| 264 | 0 | _c19980803 | |
| 008 | 199808s 0 0 eng d | ||
| 022 | _a0006-8993 | ||
| 024 | 7 |
_a10.1016/s0006-8993(98)00083-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChavko, M | |
| 245 | 0 | 0 |
_aRole of cerebral blood flow in seizures from hyperbaric oxygen exposure. _h[electronic resource] |
| 260 |
_bBrain research _cApr 1998 |
||
| 300 |
_a75-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCerebrovascular Circulation _xphysiology |
| 650 | 0 | 4 |
_aDizocilpine Maleate _xpharmacology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aHyperbaric Oxygenation _xadverse effects |
| 650 | 0 | 4 |
_aKetamine _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNitroarginine _xpharmacology |
| 650 | 0 | 4 |
_aQuinoxalines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReaction Time _xdrug effects |
| 650 | 0 | 4 |
_aSeizures _xchemically induced |
| 700 | 1 | _aBraisted, J C | |
| 700 | 1 | _aOutsa, N J | |
| 700 | 1 | _aHarabin, A L | |
| 773 | 0 |
_tBrain research _gvol. 791 _gno. 1-2 _gp. 75-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0006-8993(98)00083-3 _zAvailable from publisher's website |
| 999 |
_c9560583 _d9560583 |
||